Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United …
E Meites, TJ Wilkin, LE Markowitz - Human Vaccines & …, 2022 - Taylor & Francis
Gay, bisexual, and other men who have sex with men (MSM) and transgender women,
particularly those who are living with HIV, are disproportionately affected by human …
particularly those who are living with HIV, are disproportionately affected by human …
The politics of LGBT+ health inequality: conclusions from a UK scoping review
E McDermott, R Nelson, H Weeks - International Journal of …, 2021 - mdpi.com
This scoping review of UK evidence aimed to describe what is known about Lesbian, Gay,
Bisexual, and Trans (LGBT+) health inequalities in relation to cancer, mental health, and …
Bisexual, and Trans (LGBT+) health inequalities in relation to cancer, mental health, and …
Assessment of knowledge, attitudes, and propensity towards HPV vaccine of young adult students in Italy
C Trucchi, D Amicizia, S Tafuri, L Sticchi, P Durando… - Vaccines, 2020 - mdpi.com
Background: Human Papillomavirus (HPV) is a common sexually transmitted infection (STI),
representing the main cause of genital warts and cervical cancer. This cross-sectional study …
representing the main cause of genital warts and cervical cancer. This cross-sectional study …
[HTML][HTML] Human papillomavirus
L Luria, G Cardoza-Favarato - 2017 - europepmc.org
Human Papillomavirus - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …
HPV vaccine for men: Where to?
AD Spînu, RF Anghel, DR Marcu… - Experimental and …, 2021 - spandidos-publications.com
Human papillomavirus (HPV) is one of the most widespread human pathogens. For a long
time, it was treated as an opportunistic infection, but it is in actuality one of the most …
time, it was treated as an opportunistic infection, but it is in actuality one of the most …
Modeling the transmission dynamics and vaccination strategies for human papillomavirus infection: An optimal control approach
F Saldaña, JA Camacho-Gutiérrez… - Applied Mathematical …, 2022 - Elsevier
Human papillomavirus (HPV) vaccines have been introduced in several countries and have
shown positive results in reducing HPV infection and related diseases. Nevertheless …
shown positive results in reducing HPV infection and related diseases. Nevertheless …
Effectiveness and cost-effectiveness of human papillomavirus vaccination strategies among men who have sex with men in China: a modeling study
Introduction The health and economic benefits of human papillomavirus (HPV) vaccination
targeted at men who have sex with men (MSM) in developing settings have been rarely …
targeted at men who have sex with men (MSM) in developing settings have been rarely …
Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese …
Human papillomavirus (HPV) infection is common in women and also the main cause of
cervical cancer. Based on a dynamic compartmental model, we aimed to evaluate the …
cervical cancer. Based on a dynamic compartmental model, we aimed to evaluate the …
Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men
C Chambers, SL Deeks, R Sutradhar… - The Journal of …, 2023 - academic.oup.com
Background Real-world evidence of human papillomavirus (HPV) vaccine effectiveness
(VE) against longitudinal outcomes is lacking among gay, bisexual, and other men who …
(VE) against longitudinal outcomes is lacking among gay, bisexual, and other men who …
Importance of lifetime sexual history on the prevalence of genital human papillomavirus (HPV) among unvaccinated adults in the national health and nutrition …
Abstract Background Although the United States Food and Drug Administration recently
approved the human papillomavirus (HPV) vaccine for individuals aged 27–45 years, the …
approved the human papillomavirus (HPV) vaccine for individuals aged 27–45 years, the …